Trials & Tribulations Converting Cox hazard ratios with Cox-TEL to improve interpretation of drug efficacy in checkpoint inhibitor trials September 10, 2021Vol.47 No.33By Yu Shyr
Clinical Roundup Vaping prevention is critical as teens head back to school during pandemic September 10, 2021Vol.47 No.33
Clinical Roundup Yale Cancer Center study shows stem-like T cells could aid immunotherapy in cancer treatment September 10, 2021Vol.47 No.33
Clinical Roundup Miami Cancer Institute study shows ablative MR-guided radiation therapy may prolong survival for patients with inoperable pancreatic cancer September 10, 2021Vol.47 No.33
Drugs & Targets Active ingredient hypericin receives FDA orphan drug designation for T-cell lymphoma September 10, 2021Vol.47 No.33
Drugs & Targets Science 37, Foundation Medicine collaborate on interventional home-based clinical trials in oncology September 10, 2021Vol.47 No.33
In Brief Amy Heimberger named scientific director at Lurie Cancer Center September 03, 2021Vol.47 No.32
In Brief Ben Ho Park named deputy director of Vanderbilt-Ingram Cancer Center September 03, 2021Vol.47 No.32
In Brief Sue S. Yom named Head and Neck Cancer Committee Chair at NRG Oncology September 03, 2021Vol.47 No.32
